Status:
COMPLETED
Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Major Depressive Disorder
Eligibility:
FEMALE
18-65 years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this clinical research study is to learn whether BMS-562086 is both safe and effective in treating outpatients with major depressive disorder.
Eligibility Criteria
Inclusion
- Outpatient women meeting Diagnostic and Statistical Manual of Mental Disorders Manual, Fourth Edition, Text Revision (DSM-IV TR) criteria for a single or recurrent, non-psychotic episode of Major Depressive Disorder (296.2x and 296.3x).
- Patients whose current depressive episode is at least three months in duration at the Baseline Visit.
Exclusion
- Males
- Patients with treatment resistance to other antidepressants
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
271 Patients enrolled
Trial Details
Trial ID
NCT00135421
Start Date
November 1 2005
End Date
October 1 2007
Last Update
March 2 2010
Active Locations (45)
Enter a location and click search to find clinical trials sorted by distance.
1
Apc Clinical Research Trials Nw, Pa
Springdale, Arkansas, United States, 72762
2
Pacific Clinical Research Medical Group
Orange, California, United States, 92868
3
Pacific Clinical Research Medical Group
Upland, California, United States, 91786
4
Front Range Clinical Research
Wheat Ridge, Colorado, United States, 80033